Health
Researchers test novel gene regulation approach to treat brain diseases – News-Medical.Net
Researchers at the DZNE (Germany), at Massachusetts General Hospital (USA) and at the genomic medicine company Sangamo Therapeutics, Inc. tested a novel gene regulation…
Researchers at the DZNE (Germany), at Massachusetts General Hospital (USA) and at the genomic medicine company Sangamo Therapeutics, Inc. tested a novel gene regulation approach to treat brain diseases such as Alzheimer’s in laboratory studies. It leverages zinc finger proteins, which specifically bind to the DNA that codes for the protein Tau without altering it, thereby reducing Tau production in the brain and preventing nerve damage. The preclinical results, published in the journal Science Advances,…
-
General18 hours agoStar Wars’ fascist dystopia has never felt closer than in new season of Andor
-
Noosa News21 hours agoInterest rates: Why we will keep paying the same repayments
-
Noosa News18 hours agoQueensland Premier David Crisafulli keeps clear of Coalition chaos in Canberra
-
Business18 hours agoHere’s the average Australian superannuation balance at age 60